Susquehanna International Group’s Atossa Therapeutics ATOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,839
Closed -$246K 13144
2025
Q4
$344K Buy
38,839
+24,199
+165% +$306K ﹤0.01% 9623
2025
Q3
$190K Sell
14,640
-3,621
-20% -$44.7K ﹤0.01% 11045
2025
Q2
$227K Sell
18,261
-11,095
-38% -$133K ﹤0.01% 10943
2025
Q1
$296K Buy
29,356
+14,278
+95% +$173K ﹤0.01% 10095
2024
Q4
$214K Buy
15,078
+10,293
+215% +$201K ﹤0.01% 10595
2024
Q3
$109K Buy
+4,785
New +$96.6K ﹤0.01% 11000
2024
Q2
Sell
-18,141
Closed -$401K 12017
2024
Q1
$490K Buy
18,141
+4,478
+33% +$71.9K ﹤0.01% 8565
2023
Q4
$180K Sell
13,663
-2,904
-18% -$31.3K ﹤0.01% 10788
2023
Q3
$183K Sell
16,567
-8,302
-33% -$120K ﹤0.01% 10323
2023
Q2
$470K Buy
24,869
+17,826
+253% +$216K ﹤0.01% 8467
2023
Q1
$76.6K Buy
7,043
+610
+9% +$6.8K ﹤0.01% 11466
2022
Q4
$51K Buy
+6,433
New +$73.9K ﹤0.01% 11391
2022
Q3
Sell
-5,203
Closed -$75.6K 13135
2022
Q2
$85K Sell
5,203
-1,800
-26% -$28.4K ﹤0.01% 11617
2022
Q1
$131K Buy
7,003
+2,193
+46% +$44.6K ﹤0.01% 11690
2021
Q4
$115K Sell
4,810
-11,658
-71% -$427K ﹤0.01% 12035
2021
Q3
$805K Sell
16,468
-156,344
-90% -$9.09M ﹤0.01% 8112
2021
Q2
$16.4M Buy
172,812
+169,528
+5,162% +$8.98M 0.02% 2278
2021
Q1
$104K Sell
3,284
-3,879
-54% -$142K ﹤0.01% 11842
2020
Q4
$102K Buy
7,163
+3,759
+110% +$87K ﹤0.01% 10482
2020
Q3
$124K Sell
3,404
-1,353
-28% -$65K ﹤0.01% 9800
2020
Q2
$271K Buy
+4,757
New +$169K ﹤0.01% 8524
2018
Q3
Sell
-1,611
Closed -$53K 9226
2018
Q2
$53K Sell
1,611
-68
-4% -$3.65K ﹤0.01% 9256
2018
Q1
$135K Buy
+1,679
New +$156K ﹤0.01% 8578

Other funds holding ATOS